Edition:
United Kingdom

Alimera Sciences Inc (ALIM.OQ)

ALIM.OQ on NASDAQ Stock Exchange Global Market

0.86USD
18 Jun 2018
Change (% chg)

-- (--)
Prev Close
$0.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
27,013
52-wk High
$1.64
52-wk Low
$0.74

Chart for

About

Alimera Sciences, Inc. (Alimera) is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company operates through two segments: U.S. and International. The Company focuses on diseases affecting the back of the eye or retina. The... (more)

Overall

Beta: 2.27
Market Cap(Mil.): $95.64
Shares Outstanding(Mil.): 69.05
Dividend: --
Yield (%): --

Financials

  ALIM.OQ Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -0.40 -- --
ROI: -70.59 14.84 14.38
ROE: -- 16.34 16.07

BRIEF-Alimera Sciences Posts Q1 Loss Per Share Of $0.11

* Q1 REVENUE ROSE 48 PERCENT TO $9.8 MILLION Source text: (https://bit.ly/2KyoIEn) Further company coverage:

03 May 2018

BRIEF-Alimera Sciences Enters Into $40 Mln Term Loan Agreement With Solar Capital

* ALIMERA SCIENCES INC- ENTERED INTO A $40 MILLION TERM LOAN AGREEMENT WITH SOLAR CAPITAL LTD

08 Jan 2018

Earnings vs. Estimates